Virtu Financial’s NRX Pharmaceuticals NRXP Stock Holding History

Virtu Financial’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$68K	Buy	+31,785	New	+$64.2K	﹤0.01%	1242
2024 Q3	–	Sell	-17,043	Closed	-$42K	–	1715
2024 Q2	$42K	Buy	+17,043	New	+$60.6K	﹤0.01%	927
2023 Q2	–	Sell	-4,621	Closed	-$30K	–	1860
2023 Q1	$30K	Buy	+4,621	New	+$46.8K	﹤0.01%	1170
2022 Q3	–	Sell	-1,280	Closed	-$8K	–	2065
2022 Q2	$8K	Buy	+1,280	New	+$16.8K	﹤0.01%	1441
2022 Q1	–	Sell	-6,158	Closed	-$294K	–	1852
2021 Q4	$294K	Buy	+6,158	New	+$444K	0.03%	637
2018 Q1	–	Sell	-1,241	Closed	-$120K	–	2389
2017 Q4	$120K	Buy	+1,241	New	+$120K	0.01%	1858

Other funds holding NRXP

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial's NRXP Position: Q1 2026 in Review

Virtu Financial opened a new position in NRX Pharmaceuticals (NRXP) in Q1 2026: 31,785 shares worth $68K. The stake represents ﹤0.01% of the portfolio and ranks #1242 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NRXP as recently as Q2 2024.

Virtu Financial first reported a position in NRXP in Q4 2017 and has held it in 6 quarters since. The position peaked at $294K in Q4 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

Virtu Financial held 31,785 shares of NRX Pharmaceuticals worth $68K as of Q1 2026.
NRX Pharmaceuticals was a new Virtu Financial position in Q1 2026.
NRX Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1242 holding.
Virtu Financial first reported a position in NRX Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
Virtu Financial's NRX Pharmaceuticals position peaked at $294K in Q4 2021.
33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.